# High Risk Populations Among COPD Patients in Japan

> **NCT02413359** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1016 (actual)

## Conditions studied

- COPD

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02413359
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 1016 (ACTUAL)
- **Last updated:** 2016-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02413359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02413359, "High Risk Populations Among COPD Patients in Japan". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02413359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*